Skip to main content
SpringerLink
Log in

Testosterone therapy: increased risk of CV events

  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. FDA evaluating risk of stroke, heart attack and death with FDA-approved testosterone products. Internet Document : 3 Feb 2014. Available from: URL: http://www.fda.gov/downloads/Drugs/DrugSafety/UCM383909.pdf.

  2. Finkle WD, et al. Increased Risk of Non-Fatal Myocardial Infarction Following Testosterone Therapy Prescription in Men. PLoS One 9: e85805 [7 pages], No. 1, 3 Feb 2014.

    Article  PubMed Central  PubMed  Google Scholar 

Download references

Additional information

* see Reactions 1484 p3; 803097344

Rights and permissions

Reprints and permissions

About this article

Cite this article

Testosterone therapy: increased risk of CV events. Reactions Weekly 1489, 2 (2014). https://doi.org/10.1007/s40278-014-8882-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-014-8882-4

Search

Navigation